Key facts
| Price (PPV) | 23.20 MAD |
|---|---|
| Dispensing status | Schedule C — prescription only |
| Composition (DCI) | lansoprazole |
| Class | Drugs for acid-related disorders |
| ATC code | A02BC03 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 14 |
| Nature | Médicament |
| Hospital price | 14.50 MAD |
| Data collected on | 9/8/2026 |
Indications
• Traitement de l'ulcère duodénal et de l'ulcère gastrique ; • traitement de l'œsophagite par reflux ; • prévention de l'œsophagite par reflux ; • éradication de Helicobacter pylori (H. pylori) par administration concomitante d'une antibiothérapie appropriée pour le traitement des ulcères associés à H. pylori ; • traitement de l'ulcère duodénal et de l'ulcère gastrique bénin, induits par les AINS chez des patients nécessitant un traitement continu par AINS ; • prévention de l'ulcère duodénal et de l'ulcère gastrique induits par les AINS chez des patients à nécessitant un traitement continu par AINS; • reflux gastro-œsophagien symptomatique ; • syndrome de Zollinger-Ellison.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Lomet 15 mg (GENPHARMA) contains the same active substance as Lanzen 15 mg LP (Lansoprazole) at the same strength, but in a different pack: Boîte de 7 at 23.40 MAD, i.e. 3.34 MAD per unit against 1.66 MAD for Lanzen 15 mg LP. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Lomet 15 mg | GENPHARMA | Boîte de 14 | 32.70 MAD | 2.34 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Lomet 15 mg | GENPHARMA | Boîte de 7 | 23.40 MAD | 3.34 / unit |
| Lanzen 15 mg LP | ZENITH PHARMA | Boite de 28 | 37 MAD | 1.32 / unit |
| Lomet 15 mg | GENPHARMA | Boîte de 28 | 42 MAD | 1.50 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Lanzen 15 mg LP
Lanzen 15 mg LP belongs to the drugs for acid-related disorders therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Lanzen 15 mg LP, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Lanzen 15 mg LP
Answers to common questions from Moroccan patients about this drug.